CVS GroupCVSGF 90 Days Payable is 40.55 as of Dec. 2025, which is 23% below its 10-year median of 52.99. GuruFocus rates CVSGF with a GF Score™ of 90/100 and a GF Value™ of $18.82 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, CVS Group ranks worse than 65.51% on this metric.
CVS Group's average Accounts Payable for the
six
months ended in Dec. 2025 was $59.3 Mil. CVS Group's Cost of Goods Sold for the
six
months ended in Dec. 2025 was $266.8 Mil.
Hence, CVS Group's Days Payable for the
six
months ended in Dec. 2025 was 40.55.
The historical rank and industry rank for CVS Group's Days Payable or its related term are showing as below:
CVSGF'
s Days Payable Range Over the Past 10 Years
Min: 40.16 Med: 52.99 Max: 61.48
Current: 40.16
During the past 13 years, CVS Group's highest Days Payable was 61.48. The lowest was 40.16. And the median was 52.99.
CVSGF's Days Payable is ranked worse than 65.51% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs CVSGF: 40.16
CVS Group's Days Payable
declined
from Dec. 2024 (43.51) to Dec. 2025 (40.55).
It may suggest that CVS Groupaccelerated paying its suppliers.
CVS Group Days Payable Related Terms
CVS Group Days Payable Historical Data
* Premium members only.
The historical data trend for CVS Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, CVS Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Group Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CVS Group's Days Payable distribution charts can be found below:
* The bar in red indicates where CVS Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CVS Group's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVS Group (CVSGF) has a Days Payable of 40.55 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CVS Group and its competitors. This is 23% below median its historical median of 52.99. Over the past decade, CVS Group's Days Payable has ranged from 40.16 to 61.48. According to the industry distribution chart, CVS Group ranks #397 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 65.5%.
Is CVS Group's Days Payable too high?
CVS Group's current Days Payable of 40.55 is 23% below median its 10-year median of 52.99. Over the past 10 years, this metric has ranged from a low of 40.16 to a high of 61.48. The Healthcare Providers & Services industry median Days Payable is 58.21. CVS Group's value of 40.55 is 30.3% below this industry median. Based on the distribution chart, CVS Group ranks #397 out of 606 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, CVS Group has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CVS Group's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CVS Group ranks #397 out of 606 companies for Days Payable. This places CVS Group in the lower half of its industry. The industry median Days Payable is 58.21. CVS Group's value of 40.55 is 30.3% below this benchmark. Historically, CVS Group's own Days Payable has ranged from 40.16 to 61.48 over the past decade. While the company's 10-year median is 52.99 vs. the industry median of 58.21, CVS Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Group's current Days Payable of 40.55 is 30.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CVS Group and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Group's current Days Payable is 40.55, which is 23% below median its own 10-year median of 52.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Group stock overvalued right now?
Based on GuruFocus' analysis, CVS Group (CVSGF) is currently considered Modestly Undervalued. The stock's GF Value™ is $18.82, compared to a current price of $16.55 — trading 12.1% below its estimated fair value. The current Days Payable is 40.55, which is 23% below median its 10-year median of 52.99 and 30.3% below the Healthcare Providers & Services industry median of 58.21. CVS Group's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CVS Group (CVSGF), the current Days Payable is 40.55 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Group (CVSGF) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Group stock appears to be undervalued.
The current stock price of $16.55 is trading 12.1% below its estimated GF Value™ of $18.82.
GuruFocus considers CVS Group to be Modestly Undervalued.
Key valuation signals for CVSGF:
Days Payable: 40.55 (23% below median its 10-year median of 52.99)
GF Value™: $18.82 vs. price of $16.55 (12.1% below fair value)
Industry Position: 30.3% below the Healthcare Providers & Services median (#397 of 606)
No single metric tells the full story. See the CVSGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
90GF Score
Get the complete analysis for CVSGF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVSGF has been successfully added to your 
